MXERX
Price
$6.31
Change
-$0.59 (-8.55%)
Updated
Sep 4 closing price
Net Assets
1.22B
VSCPX
Price
$414.92
Change
+$0.06 (+0.01%)
Updated
Sep 4 closing price
Net Assets
185.27B
Interact to see
Advertisement

MXERX vs VSCPX

MXERX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
MXERX vs. VSCPX commentary
Sep 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXERX is a Buy and VSCPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 185B vs. MXERX (1.22B). MXERX pays higher dividends than VSCPX: MXERX (5.84) vs VSCPX (1.22). MXERX was incepted earlier than VSCPX: MXERX (11 years) vs VSCPX (16 years). MXERX (0.22) is less costly to investors than VSCPX (0.02). MXERX is a more actively managed with annual turnover of: 34.00 vs. VSCPX (17.00). MXERX has a lower initial minimum investment than VSCPX: MXERX (0) vs VSCPX (100000000). VSCPX annual gain was more profitable for investors over the last year : 18.58 vs. MXERX (10.81). VSCPX return over 5 years is better than : 33.37 vs. MXERX (-13.20).
MXERXVSCPXMXERX / VSCPX
Total Expense Ratio0.210.021,050%
Annual Report Gross Expense Ratio0.220.021,100%
Fund Existence11 years16 years-
Gain YTD20.84116.500126%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B185B1%
Annual Yield % from dividends5.841.22479%
Returns for 1 year10.8118.5858%
Returns for 3 years21.0352.4640%
Returns for 5 years-13.2033.37-40%
Returns for 10 years-3.55152.21-2%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTEX20.500.12
+0.59%
ICON Health and Information Tech Instl
TROSX18.50N/A
N/A
T. Rowe Price Overseas Stock
FRSIX15.56N/A
N/A
Franklin Small-Mid Cap Growth C
GCMAX40.09N/A
N/A
Goldman Sachs Mid Cap Value A
LGCRX22.22N/A
N/A
Lord Abbett Global Equity R3